across experimental systems Endogenous receptor expression in heterologous cell systems - how HEK cell biology The biological implications of many of these complexes are still being resolved.

Pfleger on NanoBRET live-cell assays, receptor complex pharmacology, and what it took to move GPCR biology The conversation also covers what it means when cell biology reaches the clinic. About the Guest Kevin Pfleger is Professor, Director of Biomedical Innovation, and Head of Molecular Endpoint Assays Can Miss the Biology Entirely A single measurement at a fixed time point collapses all That cell biology eventually became a clinical hypothesis, then a compound, then a trial result.

Kaavya Krishna Kumar on the web Journal of Biology Chemistry Stanford University Google Scholar LinkedIn

Discovering these receptors would be a significant breakthrough in cardiovascular biology as they could My long-term plan is to conduct research in the field of receptor biology, with a focus on GPCRs.

a productive, independent scientific research career in adhesion G protein-coupled receptor (aGPCR) biology linked to various neuropsychiatric phenotypes, and my work will provide a basis for understanding aGPCR biology

Bengtsson’s research spans sympathetic nervous system signaling, brown adipose tissue biology, and skeletal He is also an entrepreneur and founder of biotechnology companies translating GPCR pharmacology into Early research on brown adipose tissue and thermogenesis 22:30 Translating academic discoveries into biotech

beta-2 adrenergic receptor and GPR65 , a proton-sensing receptor with promising implications in cancer biology

For my doctoral studies, I joined the lab of Dr Andreas Russ at the Department of Biochemistry and first recruited to the Medical Faculty of Leipzig University, where I now head the Department of General Biochemistry

biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology competitive, charitable and commercial sources, as well as being academic co-founder of three GPCR-focussed biotechnology & Toxicology’, and in 2021 also named him a Highly Cited Researcher in the additional category of ‘Biology & Biochemistry’. They also emphasized the significance of fundamental discoveries, the role of biotech, and the need for

Peter Robert Banks Peter Banks is currently the Scientific Director at BioTek Instruments , now a part Before joining BioTek in 2008, Banks was employed by PerkinElmer for a decade. These roles included management of PerkinElmer’s BioPharma R&D program and Chair of the company’s Scientific Prior to experiences at PerkinElmer and BioTek, Banks was an Assistant Professor in Analytical Chemistry

exhilarating, frustrating, and baffling to the chemists who depended on consistent answers from the biologists privilege rather than a reward for good marks - 08:37 Thinking like a chemist inside the vagaries of biology

How collaborations with David Parker and Jean-Philippe Pin accelerated both probe chemistry and biological the unpredictability of product development, Or felt the thrill of seeing a tool you built drive real biological Eric Trinquet is Head of R&D for Life Sciences Reagents at Revvity, where he leads innovation in biochemical With a foundational career at Cisbio Bioassays—later acquired by Revvity—Eric played a pivotal role in

is an online platform that provides to (i) individuals and businesses such as scientists, students, biotech others with access to advertise, to promote, and market their services and products related to the biotech

talk about how I support GPCR discovery, pharmacology strategy, and cross-functional execution across biotech

Stalled Pipeline Progression ❌ Uncertainty in GPCR Investments Advisory Focus Areas Expert support for Biotech innovators, VC investors and CRO partners Biotech Pipeline Acceleration For Biotech Leaders & Scientists I integrate seamlessly with biotech, VC, and CRO teams as a trusted, objective partner. Biology-First, Data-Driven Solutions Every recommendation is rooted in GPCR biology, pharmacology experience With over two decades dedicated to GPCR pharmacology across biotech, academia, and the non-profit sector

He is Professor of Biochemistry at the Medical College of Wisconsin in Milwaukee.

signalling <p class="font_8">Watch Now</p> Sudarshan Rajagopal The Spatiotemporal Revolution in GPCR Biology GPCR Masterclass is a live scientific discussion with a leading expert in GPCR pharmacology, receptor biology designed for GPCR researchers, pharmacologists, and drug discovery scientists working in academia, biotech

He is Chief Scientific Officer and co-founder of InterAx Biotech, where he specializes in the development He also worked on creating novel methods for systems biology using temporal logic specifications while conversation about the importance of merging mathematical models and biology. his experiences transitioning from academia into the biotech sector. and relevance of mathematical models in systems biology and pharmacology.

Last summer, Julia worked at as the first-ever summer intern at Septerna, the GPCR-based biotechnology

Pierre Eftekhari "Clinical physiologist and biologist , with more than 25 years of experience in drug Inoviem scientific in Nov. 2011 by myself we have been regularly working with GPCRs for our pharma and biotech

Maria Waldhoer, CSO of InterAx Biotech AG, argues that endpoint assays — the field's default way of characterizing Maria Waldhoer is Chief Scientific Officer at InterAx Biotech AG in Switzerland. She has been at InterAx since 2017, where she leads the development of a computational systems biology 25:26 — The HEK293 experiment that predicted the animal 31:21 — Tools for the next decade: biosensors Maria Waldhoer on the web LinkedIn InterAx Biotech Pubmed Dr. GPCR Ecosystem Unlock the Full Dr.

He did B.Sc. in biology at McGill University and received his Ph.D. under the mentorship of Dr.

want to support academic labs with the same high-quality tools, courses, and insights used by leading biotech

Tried to map signaling heterogeneity in disease-relevant models, Built assays that need to work in real biology—not Michelle Halls is an Associate Professor at Monash University and Deputy Theme Leader of Drug Discovery Biology Michelle earned her PhD in Molecular Pharmacology at Monash University, then trained in single-cell biology Join a global GPCR community of scientists and biotech leaders. 👉 Join now Unlock the Full Dr.

studies the unusual signaling mechanisms employed by these atypical 7-transmembrane receptors, combining biochemical and structural approaches with cell biology and in vivo models.

Non-Profit Help Us Build a Global Home for GPCR Science Your donation bridges the gap between academia and biotech resources accessible to GPCR professionals everywhere. 💼 Job Board & Career Growth Helping researchers and biotech Help Us Close the Gap Between Academia and Biotech Together, we can accelerate GPCR discoveries and develop

melanocortin receptor accessory protein 2 (MRAP2), resulting in my first peer-reviewed publication in Biochimica et Biophysica Acta (BBA). In 2017 I officially joined the PhD program in the Department of Molecular Physiology and Biophysics While writing my thesis, I published another paper in the Journal of Biological Chemistry which described At this point in my career, I am creating connections with biomedical industry, assessing professional

Hicks About Chloe Hicks Chloe Hicks will graduate from Duke University this spring with a B.S degree in Biology

Les Houches, France in 1979 where he was exposed for the first time to the nascent field of membrane biophysics Rockefeller University with a Howard Hughes Medical Institute appointment, Tom advanced a series of novel biochemical and biophysical assay platforms, including FTIR and Raman microprobe spectroscopy to study micro-quantities applications included “targeted photo-crosslinking,” and more recently, the parallel development of bioorthogonal

Prior to Crinetics, he was senior director and head of endocrinology and metabolism at Neurocrine Biosciences Between 1992 to 1995 he led contract research efforts at Biosym Technologies to develop and apply computational